312 related articles for article (PubMed ID: 14723560)
1. Hypopigmentary skin disorders: current treatment options and future directions.
Hartmann A; Bröcker EB; Becker JC
Drugs; 2004; 64(1):89-107. PubMed ID: 14723560
[TBL] [Abstract][Full Text] [Related]
2. A rational approach to the treatment of vitiligo and other hypomelanoses.
Hercogová J; Buggiani G; Prignano F; Lotti T
Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904
[TBL] [Abstract][Full Text] [Related]
3. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis.
Li R; Qiao M; Wang X; Zhao X; Sun Q
Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo: an update on current pharmacotherapy and future directions.
Colucci R; Lotti T; Moretti S
Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
[TBL] [Abstract][Full Text] [Related]
5. Vitiligo: An Update on Pathophysiology and Treatment Options.
Speeckaert R; van Geel N
Am J Clin Dermatol; 2017 Dec; 18(6):733-744. PubMed ID: 28577207
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Vitiligo Vietnamese Patients with Vitilinex® Herbal Bio-Actives in Combination with Phototherapy.
Van TN; Minh TT; Huu DL; Huu SN; Thanh TV; Huu ND; Cam VT; Huyen ML; Hau KT; Trong HN; Gandolfi M; Satolli F; Feliciani C; Tirant M; Vojvodic A; Lotti T
Open Access Maced J Med Sci; 2019 Jan; 7(2):283-286. PubMed ID: 30745981
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
8. New and experimental treatments of vitiligo and other hypomelanoses.
Lotti T; Prignano F; Buggiani G
Dermatol Clin; 2007 Jul; 25(3):393-400, ix. PubMed ID: 17662905
[TBL] [Abstract][Full Text] [Related]
9. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
10. Current state of vitiligo therapy--evidence-based analysis of the literature.
Forschner T; Buchholtz S; Stockfleth E
J Dtsch Dermatol Ges; 2007 Jun; 5(6):467-75. PubMed ID: 17537039
[TBL] [Abstract][Full Text] [Related]
11. Vitiligo treatment in childhood: a state of the art review.
Tamesis ME; Morelli JG
Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403
[TBL] [Abstract][Full Text] [Related]
12. Ultraviolet-based therapy for vitiligo: what's new?
Hamzavi IH; Lim HW; Syed ZU
Indian J Dermatol Venereol Leprol; 2012; 78(1):42-8. PubMed ID: 22199059
[TBL] [Abstract][Full Text] [Related]
13. Topical treatment and combination approaches for vitiligo: new insights, new developments.
Hossani-Madani AR; Halder RM
G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
[TBL] [Abstract][Full Text] [Related]
14. Vitiligo.
Le Poole C; Boissy RE
Semin Cutan Med Surg; 1997 Mar; 16(1):3-14. PubMed ID: 9125760
[TBL] [Abstract][Full Text] [Related]
15. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
Scherschun L; Kim JJ; Lim HW
J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
[TBL] [Abstract][Full Text] [Related]
16. A review of monochromatic excimer light in vitiligo.
Park KK; Liao W; Murase JE
Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
[TBL] [Abstract][Full Text] [Related]
17. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma.
Vanscheidt W; Hunziker T
Dermatology; 2009; 218(4):342-3. PubMed ID: 19174603
[TBL] [Abstract][Full Text] [Related]
18. Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.
Gianfaldoni S; Tchernev G; Wollina U; Roccia MG; Fioranelli M; Lotti J; Rovesti M; Satolli F; Valle Y; Goren A; Tirant M; Situm M; Kovacevic M; França K; Lotti T
Open Access Maced J Med Sci; 2018 Jan; 6(1):46-48. PubMed ID: 29483979
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled study of the effects of different modalities of narrow-band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo.
Zhang DM; Hong WS; Fu LF; Wei XD; Xu AE
Dermatol Surg; 2014 Apr; 40(4):420-6. PubMed ID: 24446755
[TBL] [Abstract][Full Text] [Related]
20. An open randomized study to compare narrow band UVB, topical pimecrolimus and topical tacrolimus in the treatment of vitiligo.
Stinco G; Piccirillo F; Forcione M; Valent F; Patrone P
Eur J Dermatol; 2009; 19(6):588-93. PubMed ID: 19651562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
